| Milrinone | IC50 | 1500.0 [1] |
| Milrinone | Ki | 150.0 [1] |
| Rolipram | IC50 | 100000.0 [1] |
| Rolipram | Ki | 200000.0 [1] |
| Imazodan | IC50 | 6100.0 [1] |
| Sildenafil | IC50 | 10000.0 [1] |
| Amrinone | IC50 | 46000.0 [1] |
| 4,5-Dihydro-6-(4-(imidazol-1-yl)phenyl)-5-methyl-3(2H)-pyridazinone | IC50 | 600.0 [1] |
| Anagrelide | IC50 | 80.0 [1] |
| Enoximone | IC50 | 3800.0 [1], 14000.0 [2] |
| Sulmazole | IC50 | 50118.72 [1], 150000.0 [2], 500000.0 [3] |
| Cilostamide | IC50 | 10.0 [1], 170.0 [2] |
| Cilostamide | Ki | 5.0 [1], 20.0 [2] |
| Zardaverine | IC50 | 110.0 [1], 575.44 [2], 630.96 [3] |
| Lixazinone | IC50 | 3.0 [1], 10.0 [2], 10.2 [3] |
| Cilostazol | IC50 | 190.0 [1], 280.0 [2], 840.0 [3] |
| Zaprinast | IC50 | 100000.0 [1], 133000.0 [2], 660000.0 [3] |
| Cilomilast | IC50 | 3162.28 [1], 10000.0 [2] |
| 5-[1-(3,4-Dimethoxybenzoyl)-3,4-dihydro-2H-quinolin-6-yl]-6-methyl-3,6-dihydro-1,3,4-thiadiazin-2-one | IC50 | 50.0 [1], 1940.0 [2] |
| Piroximone | IC50 | 8600.0 [1], 100000.0 [2] |
| 1,3-Dihydro-7,8-dimethyl-2H-imidazo(4,5-b)quinolin-2-one | IC50 | 10.0 [1], 13.0 [2] |
| Tetrahydrobenximidazole | IC50 | 110.0 [1], 150.0 [2], 501.19 [3] |
| Theophylline | IC50 | 240000.0 [1], 360000.0 [2] |
| Tadalafil | IC50 | 10000.0 [1] |
| Vardenafil | IC50 | 580.0 [1], 2100.0 [2] |
| Isomazole | IC50 | 31622.78 [1], 42000.0 [2] |
| 2-(4-(1-(Quinolin-6-ylmethyl)-1H-[1,2,3]triazolo[4,5-b]pyrazin-6-yl)-1H-pyrazol-1-yl)ethanol | IC50 | 1300.0 [1], 7000.0 [2] |
| Indolidan | IC50 | 80.0 [1], 7000.0 [2] |
| Bemoradan | IC50 | 300.0 [1] |
| 5-(2-Ethoxyphenyl)-1-methyl-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-7(6H)-one | IC50 | 500.0 [1], 100000.0 [2] |
| 2(1H)-Quinolinone, 3,4-dihydro-1-methyl-6-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)- | IC50 | 100.0 [1], 120.0 [2] |
| 4-[8-(3-Nitrophenyl)-1,7-naphthyridin-6-yl]benzoic Acid | IC50 | 10000.0 [1], 100000.0 [2] |
| CI-1018 | IC50 | 35800.0 [1], 100000.0 [2] |
| 6-(4-Imidazol-1-yl-phenyl)-2H-pyridazin-3-one | IC50 | 7200.0 [1] |
| 6-[4-(1H-Imidazol-2-yl)-phenyl]-2H-pyridazin-3-one | IC50 | 12000.0 [1] |
| 6-(3-Imidazol-1-yl-phenyl)-4,5-dihydro-2H-pyridazin-3-one | IC50 | 40000.0 [1] |
| 6-(4-(1H-Imidazol-1-yl)phenyl)-5-methylpyridazin-3(2H)-one | IC50 | 50000.0 [1] |
| N-[(11R)-6-Methoxy-12-oxo-9-phenyl-1,10-diazatricyclo[6.4.1.04,13]trideca-4(13),5,7,9-tetraen-11-yl]isoquinoline-3-carboxamide | IC50 | 82000.0 [1], 82300.0 [2] |
| 4-Amino-3,5-dichloro-N-[(11R)-6-methyl-12-oxo-9-phenyl-1,10-diazatricyclo[6.4.1.04,13]trideca-4(13),5,7,9-tetraen-11-yl]benzamide | IC50 | 10300.0 [1], 17500.0 [2] |
| N-[(11R)-6-Methyl-12-oxo-9-phenyl-1,10-diazatricyclo[6.4.1.04,13]trideca-4(13),5,7,9-tetraen-11-yl]isoquinoline-3-carboxamide | IC50 | 100000.0 [1] |
| 2-Methoxy-N-[(11R)-6-methyl-12-oxo-9-phenyl-1,10-diazatricyclo[6.4.1.04,13]trideca-4(13),5,7,9-tetraen-11-yl]benzamide | IC50 | 28800.0 [1], 100000.0 [2] |
| N-[(11R)-12-Oxo-9-phenyl-1,10-diazatricyclo[6.4.1.04,13]trideca-4(13),5,7,9-tetraen-11-yl]isoquinoline-3-carboxamide | IC50 | 100000.0 [1] |
| N-[(11R)-6-Methoxy-12-oxo-9-phenyl-1,10-diazatricyclo[6.4.1.04,13]trideca-4(13),5,7,9-tetraen-11-yl]pyridine-4-carboxamide | IC50 | 40800.0 [1], 41000.0 [2] |
| 7-Methoxy-3,5-dihydro-1H-imidazo[2,1-b]quinazolin-2-one | IC50 | 1500.0 [1] |
| 4-(2-Oxo-1,2,3,5-tetrahydro-imidazo[2,1-b]quinazolin-7-yloxy)-butyric acid | IC50 | 40.0 [1], 280.0 [2] |
| Ethyl 4-[(2-oxo-3,5-dihydro-1H-imidazo[2,1-b]quinazolin-7-yl)oxy]butanoate | IC50 | 70.0 [1], 240.0 [2] |
| 7-Hexoxy-3,5-dihydro-1H-imidazo[2,1-b]quinazolin-2-one | IC50 | 290.0 [1] |
| 2,4,4a,5-Tetrahydro-7-(1H-imidazol-1-yl)-3H-indeno[1,2-c]pyridazin-3-one | IC50 | 1800.0 [1] |
| 2,5-Dihydro-7-(1H-imidazol-1-yl)-3H-indeno[1,2-c]pyridazin-3-one | IC50 | 1600.0 [1] |
| 6,7-Dimethoxy-9-(3,4,5-trimethoxy-phenyl)-3H-naphtho[2,3-c]furan-1-one | IC50 | 300.0 [1], 320.0 [2] |
| 4-Methyl-7-(4-methyl-6-oxo-4,5-dihydro-1H-pyridazin-3-yl)-1,4-benzoxazin-3-one | IC50 | 300.0 [1] |
| 8-(3-Chlorophenyl)-6-(pyridin-4-ylmethyl)pyrido[2,3-d]pyridazin-5-one | IC50 | 5100.0 [1] |
| [3-Hydroxymethyl-6,7-dimethoxy-1-(3,4,5-trimethoxy-phenyl)-naphthalen-2-yl]-methanol | IC50 | 880.0 [1], 900.0 [2] |
| 2-Butyl-4-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methylsulfanyl]quinazoline | IC50 | 8.0 [1], 8000.0 [2] |
| 4,7-Dimethyl-N-[(11R)-6-methyl-12-oxo-9-phenyl-1,10-diazatricyclo[6.4.1.04,13]trideca-4(13),5,7,9-tetraen-11-yl]pyrazolo[5,1-c][1,2,4]triazine-3-carboxamide | IC50 | 100000.0 [1] |
| 9-[(2-Fluorophenyl)methyl]-N-methylpurin-6-amine;methanesulfonic acid | IC50 | 121000.0 [1] |
| 9-[(2-Fluorophenyl)methyl]-N-methylpurin-6-amine;methanesulfonic acid | Ki | 35000.0 [1] |
| Cyclic guanosine monophosphate | IC50 | 2400.0 [1] |
| Losartan | IC50 | 13000.0 [1] |
| Dipyridamole | IC50 | 43000.0 [1] |
| 2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | IC50 | 100000.0 [1] |
| Losartan potassium | IC50 | 13000.0 [1] |
| Hydroxyhomosildenafil | IC50 | 62000.0 [1] |
| Desmethylsildenafil | IC50 | 100000.0 [1] |
| Levosimendan | IC50 | 8.0 [1] |
| Simendan | IC50 | 1500.0 [1] |
| Vardenafil hydrochloride | IC50 | 500.0 [1] |
| 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone | IC50 | 300000.0 [1] |
| (2R,3S)-3-(6-Amino-9H-purin-9-yl)nonan-2-ol | Ki | 200000.0 [1] |
| Pimobendan | IC50 | 410.0 [1] |
| Vesnarinone | IC50 | 6200.0 [1] |
| Etazolate | Ki | 12000.0 [1] |
| Proxyphylline | Ki | 1000000.0 [1] |
| Crisaborole | IC50 | 6400.0 [1] |
| 9-Benzyladenine | IC50 | 200000.0 [1] |
| Cipargamin | IC50 | 10000.0 [1] |
| Quazinone | IC50 | 240.0 [1] |
| Oxagrelate | Ki | 1400.0 [1] |
| Sodium;1-[4-(1,3-benzodioxol-5-ylmethylamino)-6-chloroquinazolin-2-yl]piperidine-4-carboxylate | IC50 | 100000.0 [1] |
| Sgx-523 | IC50 | 3000.0 [1] |
| 1,5-Dihydro-7-(1-piperidinyl)-imidazo(2,1-b)quinazolin-2(3H)-one | IC50 | 150.0 [1] |
| 1-(3-Chlorophenylamino)-4-phenylphthalazine | Ki | 16000.0 [1] |
| (R)-(-)-Rolipram | IC50 | 3162.28 [1] |
| Jnj-38877605 | IC50 | 4000.0 [1] |
| CI-1044 | IC50 | 100000.0 [1] |
| Chf-6001 | IC50 | 1000.0 [1] |
| Methyl 2-(4-aminophenyl)-1-oxo-7-(pyridin-2-ylmethoxy)-4-(3,4,5-trimethoxyphenyl)isoquinoline-3-carboxylate;sulfuric acid | IC50 | 100000.0 [1] |
| 1H-Purine-2,6-dione, 3,7-dihydro-7-(2-hydroxypropyl)-1,3-dimethyl-, (S)- | Ki | 1200000.0 [1] |
| (2S,3R)-3-(6-Amino-9H-purin-9-yl)nonan-2-ol | IC50 | 16000.0 [1] |
| T 0156 Hydrochloride | IC50 | 100000.0 [1] |
| N-[(11R)-9-(2-Fluorophenyl)-12-oxo-1,10-diazatricyclo[6.4.1.04,13]trideca-4(13),5,7,9-tetraen-11-yl]-1H-indole-2-carboxamide | IC50 | 100000.0 [1] |
| 4-Acetyl-1-methyl-7-(4-pyridyl)-5,6,7,8-tetrahydro-3(2H)-isoquinolinone | IC50 | 1500.0 [1] |
| 6-(Pyridin-3-yl)-3,4-dihydroquinolin-2(1H)-one | IC50 | 4400.0 [1] |
| Nitraquazone | IC50 | 200000.0 [1] |
| N-Benzyl-2-phenyl-4-quinazolinamine | IC50 | 100000.0 [1] |
| 3,3-Dimethyl-5-(4-methyl-6-oxo-4,5-dihydro-1H-pyridazin-3-yl)-1H-indol-2-one | IC50 | 12.59 [1] |
| 6-{(1S)-1-[6-(1-Methyl-1H-pyrazol-4-yl)[1,2,4]triazolo[4,3-b]pyridazin-3-yl]ethyl}quinoline | IC50 | 170.0 [1] |
| N-Benzyl-2-(pyridin-3-yl)quinazolin-4-amine | IC50 | 100000.0 [1] |
| 4-Ethyl-1,3-dihydro-5-(4-(2-methyl-1H-imidazol-1-yl)benzoyl)-2H-imidazol-2-one | IC50 | 37000.0 [1] |
| 7-Bromo-3,6-dimethyl-3,5-dihydro-1H-imidazo[2,1-b]quinazolin-2-one | IC50 | 70.0 [1] |